Cargando…
Botulinum Neurotoxin Type A Subtype 2 Confers Greater Safety than Subtype 1 in a Rat Parkinson’s Disease Model
Botulinum neurotoxin type A (BoNT/A) cleaves SNAP-25 and interrupts the release of acetylcholine. We previously reported that BoNT/A subtype 2 (BoNT/A2) ameliorates pathologic behavior more effectively than subtype 1 (BoNT/A1) in a rat Parkinson’s disease model. Here, we further show BoNT/A2 has few...
Autores principales: | ITAKURA, Masanori, KOHDA, Tomoko, KUBO, Takeya, SEMI, Yuko, NISHIYAMA, Kazuhiro, AZUMA, Yasu-Taka, NAKAJIMA, Hidemitsu, KOZAKI, Shunji, TAKEUCHI, Tadayoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155206/ https://www.ncbi.nlm.nih.gov/pubmed/24849052 http://dx.doi.org/10.1292/jvms.14-0184 |
Ejemplares similares
-
Clinical Safety and Tolerability of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Botulinum Neurotoxin Subtype A2, in Comparison with Subtype A1 Toxins
por: Takeuchi, Toshiaki, et al.
Publicado: (2021) -
Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Aggregation Causes Mitochondrial Dysfunction during Oxidative Stress-induced Cell Death
por: Nakajima, Hidemitsu, et al.
Publicado: (2017) -
A Pilot Study of A2NTX, a Novel Low-Molecular-Weight Neurotoxin Derived from Subtype A2 for Post-Stroke Lower Limb Spasticity: Comparison with OnabotulinumtoxinA
por: Kaji, Ryuji, et al.
Publicado: (2022) -
Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
por: Peck, Michael W., et al.
Publicado: (2017) -
Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6
por: Moritz, Molly S., et al.
Publicado: (2018)